share_log

Ginkgo Bioworks | S-3: Registration statement for specified transactions by certain issuers

Ginkgo Bioworks | S-3: Registration statement for specified transactions by certain issuers

Ginkgo Bioworks | S-3：特定交易注册声明
美股sec公告 ·  05/09 17:19
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc., a Delaware corporation, filed a Form S-3 registration statement with the Securities and Exchange Commission (SEC) on May 9, 2024. The filing pertains to the resale or disposition of up to 18,857,026 shares of Class A common stock by selling securityholders, which includes entities such as AgBiome, Inc. The shares may be sold from time to time in a variety of methods, including on stock exchanges, in private transactions, or through broker-dealers. Ginkgo Bioworks will not receive any proceeds from the sale of these shares. The registration statement also includes provisions for indemnification of officers and directors, the company's capital stock description, and the appointment of powers of attorney. The selling securityholders may include donees, pledgees, or other transferees who receive shares after the prospectus date. The registration allows these parties to resell their shares publicly.
Ginkgo Bioworks Holdings, Inc., a Delaware corporation, filed a Form S-3 registration statement with the Securities and Exchange Commission (SEC) on May 9, 2024. The filing pertains to the resale or disposition of up to 18,857,026 shares of Class A common stock by selling securityholders, which includes entities such as AgBiome, Inc. The shares may be sold from time to time in a variety of methods, including on stock exchanges, in private transactions, or through broker-dealers. Ginkgo Bioworks will not receive any proceeds from the sale of these shares. The registration statement also includes provisions for indemnification of officers and directors, the company's capital stock description, and the appointment of powers of attorney. The selling securityholders may include donees, pledgees, or other transferees who receive shares after the prospectus date. The registration allows these parties to resell their shares publicly.
特拉华州的一家公司Ginkgo Bioworks Holdings, Inc. 于2024年5月9日向美国证券交易委员会（SEC）提交了S-3表格的注册声明。该文件涉及通过出售证券持有人（包括Agbiome, Inc.等实体）转售或处置多达18,857,026股A类普通股。这些股票可以不时通过各种方式出售，包括在证券交易所、私人交易中或通过经纪交易商出售。Ginkgo Bioworks不会从出售这些股票中获得任何收益。注册声明还包括对高管和董事的赔偿、公司的股本说明以及委托书的任命等条款。出售证券持有人可能包括受赠人、质押人或其他在招股说明书日之后获得股票的受让人。注册允许这些各方公开转售其股份。
特拉华州的一家公司Ginkgo Bioworks Holdings, Inc. 于2024年5月9日向美国证券交易委员会（SEC）提交了S-3表格的注册声明。该文件涉及通过出售证券持有人（包括Agbiome, Inc.等实体）转售或处置多达18,857,026股A类普通股。这些股票可以不时通过各种方式出售，包括在证券交易所、私人交易中或通过经纪交易商出售。Ginkgo Bioworks不会从出售这些股票中获得任何收益。注册声明还包括对高管和董事的赔偿、公司的股本说明以及委托书的任命等条款。出售证券持有人可能包括受赠人、质押人或其他在招股说明书日之后获得股票的受让人。注册允许这些各方公开转售其股份。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息